Kwang Dong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	140,991	116,189	77,344	103,552	83,966
Short-Term Investments	-0	-	-	-	9,369
Trading Asset Securities	86,698	49,261	128,837	105,080	94,366
Cash & Short-Term Investments	227,690	165,450	206,181	208,632	187,701
Cash Growth	37.62%	-19.75%	-1.18%	11.15%	25.74%
Accounts Receivable	274,958	270,639	256,830	224,530	237,863
Other Receivables	4,664	3,773	5,513	2,734	3,568
Receivables	280,623	276,052	262,402	227,311	241,486
Inventory	203,574	217,247	188,643	161,410	152,493
Prepaid Expenses	1,866	2,350	1,766	2,017	2,370
Other Current Assets	3,879	55,762	6,432	6,376	3,769
Total Current Assets	717,631	716,862	665,424	605,747	587,818
Property, Plant & Equipment	269,462	249,038	212,432	153,532	138,013
Long-Term Investments	143,777	114,011	96,139	93,686	83,604
Goodwill	27,875	21,694	21,694	6,119	6,119
Other Intangible Assets	21,266	15,941	15,008	9,975	10,592
Long-Term Deferred Tax Assets	15,969	14,154	12,960	10,536	8,365
Long-Term Deferred Charges	10.05	-	-	-	-
Other Long-Term Assets	121,774	37,760	52,214	50,247	46,982
Total Assets	1,320,329	1,170,275	1,078,065	932,024	883,845
Accounts Payable	192,219	169,802	171,051	174,051	153,527
Accrued Expenses	3,040	1,871	1,862	1,691	1,079
Short-Term Debt	210,475	208,940	187,834	113,006	93,006
Current Portion of Long-Term Debt	20,760	2,472	24,202	-	15,000
Current Portion of Leases	7,529	3,128	1,913	1,362	1,109
Current Income Taxes Payable	14,114	8,186	8,941	8,338	10,179
Current Unearned Revenue	309.4	310.94	291.6	331.8	331.4
Other Current Liabilities	77,474	66,589	60,714	54,786	51,263
Total Current Liabilities	525,920	461,299	456,810	353,567	325,495
Long-Term Debt	54,683	66,444	19,028	21,962	21,934
Long-Term Leases	9,760	4,938	2,664	1,675	997.64
Long-Term Unearned Revenue	356.37	-	-	-	-
Pension & Post-Retirement Benefits	0	-0	0	-0	-0
Long-Term Deferred Tax Liabilities	5,168	4,440	2,173	1,675	2,717
Other Long-Term Liabilities	12,645	14,888	9,344	6,099	5,457
Total Liabilities	608,533	552,008	490,018	384,978	356,600
Common Stock	52,421	52,421	52,421	52,421	52,421
Additional Paid-In Capital	70,802	58,171	55,299	55,277	55,223
Retained Earnings	540,134	520,907	485,155	453,838	433,215
Treasury Stock	-12,074	-57,124	-53,057	-46,822	-46,822
Comprehensive Income & Other	4,297	4,747	4,798	2,616	5,140
Total Common Equity	655,579	579,122	544,616	517,331	499,177
Minority Interest	56,217	39,145	43,431	29,716	28,068
Shareholders' Equity	711,796	618,267	588,047	547,046	527,245
Total Liabilities & Equity	1,320,329	1,170,275	1,078,065	932,024	883,845
Total Debt	303,208	285,921	235,641	138,006	132,046
Net Cash (Debt)	-75,518	-120,471	-29,460	70,627	55,655
Net Cash Growth	-	-	-	26.90%	40.66%
Net Cash Per Share	-1876.39	-3008.73	-727.94	1719.22	1353.21
Filing Date Shares Outstanding	43.14	39.34	40.08	41.08	41.08
Total Common Shares Outstanding	43.14	39.34	40.08	41.08	41.08
Working Capital	191,711	255,563	208,615	252,180	262,323
Book Value Per Share	15195.02	14719.33	13588.02	12593.06	12151.16
Tangible Book Value	606,438	541,487	507,915	501,237	482,467
Tangible Book Value Per Share	14056.03	13762.78	12672.32	12201.30	11744.38
Land	65,001	62,710	74,423	65,921	65,840
Buildings	193,949	150,395	95,003	77,283	75,616
Machinery	185,876	157,259	152,469	129,099	124,756
Construction In Progress	2,516	40,678	52,582	23,534	5,237

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.